![]() David Kyne |
Evoke, healthcare, medical marketing and communications unit of Huntsworth, has acquired independent health PR specialist KYNE, the ten-year-old shop that registered $10.4M in fees on O'Dwyer's 2018 rankings of healthcare firms.
KYNE and Evoke's PR & Influence unit, which offers strategic communications, PA, investor relations and consumer marketing services, will join to form a new entity
David Kyne will head Evoke KYNE, reporting to Evoke CEO Reid Connolly.
Evoke PR & Influence president Maryellen Royle, KYNE EVP, GM Maureen Byrne and KYNE EVP Wendy Woods-Williams will serve as partners at Evoke KYNE.
“This acquisition is a wonderful event for both our clients and our teams,” Royle told O’Dwyer’s. “Our healthcare client base, in both the private and public sectors, will gain access to new talent, thinking and resources across a much broader geographic reach. And for our internal team, it offers fresh opportunities for them to leverage their unique communications expertise across a more diverse portfolio.”
Evoke reported $12M in PR fees on O'Dwyer's healthcare rankings list.


Science is a journey of discovery, not a destination. The recent clinical trial disappointments involving Novartis and Novo Nordisk offer an important opportunity to reflect on the nature of scientific progress.
To make sure that the messages an annual meeting is supposed to deliver connect with their audiences, focus on the big story behind the complex data.
It’s not enough to simply be a good storyteller. Communicators now need to be explainers—making a range of complex subjects understandable to consumers.
Building awareness is no longer enough. Marketing and communications must ensure that when buyers begin researching a category, the company is visible, credible and differentiated.
With AI facing blowback from many audiences, it is becoming increasingly important to make sure that the human side of your communications comes through.



